Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Dehay

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Biotechnology Journal|March 22, 2007
Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicityBenjamin Dehay, Chantal Weber, Yvon Trottier, et al.
Pharmaceutics|August 10, 2021
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative DiseasesAnthony Cunha, Alexandra Gaubert, Laurent Latxague, et al.
Synapse (New York, N.Y.)|December 24, 2015
Harnessing the trophic and modulatory potential of statins in a dopaminergic cell lineMathieu Schmitt, Benjamin Dehay, Erwan Bezard, et al.
Synapse (New York, N.Y.)|April 14, 2017
U18666A, an activator of sterol regulatory element binding protein pathway, modulates presynaptic dopaminergic phenotype of SH-SY5Y neuroblastoma cellsMathieu Schmitt, Benjamin Dehay, Erwan Bezard, et al.
Scientific Reports|February 23, 2012
Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaquesBenjamin Dehay, Deniz Dalkara, Sandra Dovero, et al.
Nature Reviews. Neuroscience|December 15, 2021
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Frontiers in Chemistry|September 7, 2021
Nucleolipid Acid-Based Nanocarriers Restore Neuronal Lysosomal Acidification DefectsMathias Brouillard, Philippe Barthélémy, Benjamin Dehay, et al.
Journal of Parkinson'S Disease|February 20, 2025
Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the diseaseDavid Bendetowicz, Vincent Planche, Erwan Bezard, et al.
Scientific Reports|April 5, 2017
Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the modelMathieu Bourdenx, Sandra Dovero, Marie-Laure Thiolat, et al.
Scientific Reports|December 4, 2012
Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primateMarie-Hélène Canron, Martine Perret, Anne Vital, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Biotechnology Journal|March 22, 2007
Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicityBenjamin Dehay, Chantal Weber, Yvon Trottier, et al.
Pharmaceutics|August 10, 2021
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative DiseasesAnthony Cunha, Alexandra Gaubert, Laurent Latxague, et al.
Synapse (New York, N.Y.)|December 24, 2015
Harnessing the trophic and modulatory potential of statins in a dopaminergic cell lineMathieu Schmitt, Benjamin Dehay, Erwan Bezard, et al.
Synapse (New York, N.Y.)|April 14, 2017
U18666A, an activator of sterol regulatory element binding protein pathway, modulates presynaptic dopaminergic phenotype of SH-SY5Y neuroblastoma cellsMathieu Schmitt, Benjamin Dehay, Erwan Bezard, et al.
Scientific Reports|February 23, 2012
Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaquesBenjamin Dehay, Deniz Dalkara, Sandra Dovero, et al.
Nature Reviews. Neuroscience|December 15, 2021
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Frontiers in Chemistry|September 7, 2021
Nucleolipid Acid-Based Nanocarriers Restore Neuronal Lysosomal Acidification DefectsMathias Brouillard, Philippe Barthélémy, Benjamin Dehay, et al.
Journal of Parkinson'S Disease|February 20, 2025
Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the diseaseDavid Bendetowicz, Vincent Planche, Erwan Bezard, et al.
Scientific Reports|April 5, 2017
Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the modelMathieu Bourdenx, Sandra Dovero, Marie-Laure Thiolat, et al.
Scientific Reports|December 4, 2012
Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primateMarie-Hélène Canron, Martine Perret, Anne Vital, et al.
Pageof 10